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 Cognitive-behavioral therapy (CBT) with exposure is an effective treatment for 
anxiety disorders but involves acute discomfort, rendering treatment engagement a 
challenge. Willingness to engage in exposure is of interest, because a child has to 
willingly approach a feared stimulus. This preliminary study investigated child 
engagement during exposures in CBT for anxiety disorders, with the development, 
validation, and field testing of a measure of self-efficacy over three time points. The 
measure, Self-Efficacy During Exposure-Child (SEE-C), is a 9-item, self-report measure 
of self-efficacy during exposure for youth 8-17 years old. A sample of eight reviewers at 
least 2-years post licensure (M = 14.06; SD = 4.71) with expertise in CBT for childhood 
anxiety provided feedback on the SEE-C’s face and content validity. Field testing 
included a sample of 24 child-parent dyads recruited from an anxiety clinic in the 
Northeast U.S. Child-parent dyads were asked to complete measures of child self-
efficacy; child anxiety symptoms; and child school, social, and family functioning. 
Children were also asked to complete a measure of motivation. Analyses revealed the 
SEE-C to demonstrate significant increases in child self-efficacy, reductions in child 
anxiety symptoms, and increases in social and family functioning over treatment. Internal 
consistency of the SEE-C was acceptable to excellent, and exploratory principle 
component analysis suggested a three-factor solution, with loadings ranging from 0.5 to 
0.9. The SEE-C adds to the literature as the first measure of child self-efficacy designed 
for use during exposure in CBT for anxiety. Findings provide insight into those factors 
that contribute to a child’s engagement during exposure. Reported effect sizes are 
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 Anxiety disorders among children and adolescents require effective 
interventions due to their often unrelenting symptomatology causing distress and 
impairment in family, academic, and social functioning, as well as reduced quality of 
life (Costello, Egger, & Angold, 2005; Ezpeleta, Keeler, Erkanli, Costello, & Angold, 
2001; Piacentini, Bergman, Keller, & McCracken, 2003; Valderhaug & Ivarsson, 
2005). Cognitive-behavioral therapy (CBT) for anxiety disorders among children and 
adolescents, particularly those incorporating exposure practice, have been empirically 
supported and denoted efficacious by a considerable amount of clinical outcome 
research (e.g., Compton, Peris, Almirall, Birmaher, Sherrill, Kendall, et al., 2014; 
Higa-McMillan, Francis, Rith-Najarian, & Chorpita, 2015; Kendall, Flannery-
Schroeder, Panichelli-Mindel, Southam-Gerow, Henin, & Warman, 1997). CBT with 
exposure is a variant of CBT that is purported to work via exposure, where exposure is 
defined as “a controlled therapeutic task in which a person confronts an anxiety-
provoking stimulus or situation” (Marks, 1973). As such, anxiety and fear reduction 
occurs through contact with the feared stimulus.  
 While CBT with exposure is identified as an effective treatment for childhood 
anxiety disorders, it involves much acute discomfort, thus rendering treatment 
engagement during exposure with children and adolescents a challenge. A focus on 
exposure practice during treatment is necessary, however, as it is considered a primary 
mechanism and an active “ingredient” in anxiety reduction (Peris et al., 2015). As a 
result, questions about the exposure process have arisen.  For example, how does a 
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child in CBT for anxiety begin to engage in and utilize exposure to “fight” their 
anxiety?  Also, when does the child begin to experience a reduction in anxiety during 
exposure? Further, does a reduction of a child’s anxiety during exposure within 
session lead to future reductions of anxiety during exposure across session within the 
CBT with exposure treatment trajectory?  
 Social psychology, sports psychology, and behavioral economics each study 
the performance-enhancing concept of positive psychological momentum (PPM). 
Rooted in attribution theory (the study of the processes by which individuals explain 
the causes of behavior and events), PPM is defined as the “perception, attitude, belief, 
or state-of-mind an individual experiences, in which their initial success leads to more 
successes” (Iso-Ahola & Blanchard, 1986). Positive psychological momentum theory 
posits that perceived positive momentum leads to increased confidence; thus, in turn, 
leading to more active and better performance (Rosenqvist & Nordström Skans, 2015). 
In line with this phenomenon, Compte and Postlewaite (2004) suggest that a causal 
link may exist from past successes to future performance through “confidence,” where 
confidence is defined as one's belief in one's ability to succeed in specific situations or 
accomplish a task (Iso-Ahola & Dotson, 2014). However, given the definition of 
confidence, it seems that before an individual can perceive confidence, they have to 
first perceive self-efficacy.  Self-efficacy is the belief one has about their ability to 
perform a certain task (Bandura, 1997 & 1988); thus, one will have confidence when 
self-efficacy is utilized to competently complete a task multiple times. The concept of 
PPM may also be used to explain enhanced performance within the context of 
enhancing a child/adolescent’s motivation (the process that initiates, guides, and 
maintains goal-oriented behaviors). The theory of PPM, if shown to have a causal 
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relationship with self-efficacy and motivation by which “success leads to success,” 
could be used to enhance performance not only within sports or entrepreneurial 
endeavors, but also within the context of enhancing youth motivation and self-efficacy 
to complete exposure tasks in CBT treatments. 
Child Engagement During Exposure in CBT for Childhood Anxiety Disorders 
 A child’s willingness to engage in and adhere to exposure practice during CBT 
is of great interest, because exposures cannot be “done” to a child. Rather, a child has 
to willingly participate in a task that focuses on a feared stimulus in order for the fear 
to reduce. Engagement (the act of occupying the attention or efforts of a person, and in 
this case, a child) in exposure is made up of multiple factors. However, to date, there 
is a significant gap in the literature, as no investigations have been found related to 
child factors that contribute to engagement during the utilization of exposure. Thus, 
the study of these factors is needed.  
 While no studies have examined child engagement during exposure sessions, 
some research has investigated child engagement more generally during CBT 
treatment. For example, Morgan and colleagues (2013) explored the relationship 
between poor treatment adherence and attenuated treatment response in pediatric OCD 
and found that a child’s willingness to engage in exposure mediated overall treatment 
outcomes. Morgan and colleagues’ (2013) study supports the need for additional 
research regarding treatment engagement in exposure, yet, does not examine the child-
specific factors that may be identified as necessary for engagement during exposure.  
 Relatedly, King, Currie, and Petersen (2014) examined factors of child 
engagement in mental health treatment and assert that it involves a motivational 
commitment to the intervention process. They suggested that this process includes 
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behavioral involvement such as child in-session participation, therapist and child 
collaboration, and the child’s self-efficacy to continue in the identified intervention. 
Thus, a child’s in-session motivation to experience and feel distress in the face of a 
feared stimulus along with their perceived self-efficacy may be two important factors 
in engagement during exposure. 
 While there are many factors that make up child and adolescent treatment 
engagement during exposure in CBT for childhood anxiety, including caregiver 
(hereinafter referred to as “parent”) factors and clinician factors, motivation and 
perceived self-efficacy are two child factors purported to contribute to engagement 
within the theory of positive psychological momentum. Yet, there is a real need for the 
development of assessment tools to measure these constructs. The present study will 
focus on the latter (i.e., self-efficacy), as a review of the literature demonstrates the 
absence of such a measure. 
Self-efficacy: A Factor to be Explored 
 Perceived self-efficacy has been studied within the context of fear reduction 
and phobias (Bandura, 1977, 1978, 1982, 1998) and is posited to improve one’s 
expectation of achievement. Though perceived self-efficacy does not cause the 
reduction of fear (Tryon, 2005), it may function as an anchor for a child to engage in 
exposure practice and a platform for a child to engage in additional and more difficult 
exposure practice between sessions. This is notable, as Bandura (1997) maintained 
that perceived self-efficacy influences one’s motivation to act or to persevere in the 
face of difficulties. 
 There are multiple empirical investigations on child and adolescent perceived 
self-efficacy reported in the literature. For instance, Tonge, King, Klimkeit, Melvin, 
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Heyne, and Gordon (2005) developed and tested a measure of perceived self-efficacy 
about coping with depressive symptoms in adolescents and found the measure’s 
psychometric properties to be acceptable. Study results indicated higher pre-treatment 
self-efficacy scores predicted better outcomes at three and six months post-treatment. 
Similarly, Bandura and colleagues (1999) determined that perceived self-efficacy 
influenced childhood depression and contributed to concurrent and subsequent 
depression. Additionally, Warren and Salazar (2015) observed self-efficacy to be 
associated with improvements in youth-reported symptoms of emotional distress and 
behavioral dysfunction in routine mental health services. Self-efficacy has also been 
found to be predictive of performance on cognitive tasks, such as academic 
achievement and social adaptation (Magno & Lajom, 2008; Pastorelli, Caprara, 
Barbaranelli, Rola, Rozsa, & Bandura, 2001). Multiple child and adolescent health 
studies have also revealed high perceived self-efficacy to be predictive of proper 
management of chronic conditions, such as weight loss behaviors (Walpole, Dettmer, 
Morrongiello, McCrindle, & Hamilton, 2011), smoking behaviors (Ford, Oladopo, 
Sterling, Diamond, Kelder, & McAlister, 2013), chronic pain (Bursch, Tsao, 
Meldrum, & Zeltzer, 2006), chronic illness (Emerson et al., 2018) and exercise-related 
behaviors (Pakarinen, Parisod, Smed, & Salantera, 2017). Considering the extant 
literature on child perceived self-efficacy and child engagement during treatment, self-
efficacy is an important factor to be explored in a study of engagement during 
exposure.  
The Current Study  
 The current study reports the development, psychometric evaluation, and field 
testing of a measure of child/adolescent perceived self-efficacy to be used during 
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exposure in CBT for children and adolescents with anxiety disorders. The purpose of 
the measure is to facilitate the understanding of child/adolescent factors that contribute 
to treatment engagement during exposure.  
  The study was conducted in two parts: 1. The development and psychometric 
evaluation of the measure, including expert review and child response feedback, and 2. 
Field testing of the measure to examine the relationship of child perceived self-
efficacy to other variables during CBT for anxiety among children and adolescents. 
See Study Flow Chart in Figure 1. 
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The following hypotheses were tested: Hypothesis 1. Development of the Self-
Efficacy during Exposure – Child version (SEE-C). Hypothesis 1a: Expert review will 
appropriately tailor the SEE-C to the age and population of	youth	with	anxiety	
disorders on content validity and face validity. Hypothesis 1b: Participant review will 
guide revisions to the SEE-C’s instructions, items, and item responses to assist with 
validity of the measure. Hypothesis 1c: The internal consistency of the SEE-C will meet 
or exceed α = .70. 
 Hypothesis 2. Examination of the relationship between the SEE-C and other key 
variables. Hypothesis 2a: Self-efficacy, as measured by the SEE-C, will be related at pre-
treatment (and overtime) to anxiety symptoms, as measured by the Spence Children’s 
Anxiety Scale (SCAS) and anxiety functional impairment, as measured by the Child 
Sheehan Disability Scale for Anxiety (CSDS). Hypothesis 2b: Self-efficacy, as measured 
by the SEE-C, will be related overtime to clinical improvement, as measured by the 
Clinical Global Impression Scale (CGI). Hypothesis 2c: Self-efficacy, as measured by the 
SEE-C, will be related at pretreatment (and overtime) to state motivation, as measured by 









 Expert review. A sample of eight clinicians at least two-years post licensure with 
expertise in the cognitive-behavioral treatment of childhood anxiety disorders was 
identified and recruited for participation in the present study. Expert reviewers (88% 
Female) endorsed employment throughout the United States from multiple clinical and 
academic sites: Four were from universities, three were from academic medical centers, 
and one was from both a medical center and private practice. Experts were at least two 
years post licensure (M = 14.06 years; SD = 4.71), with more than 15 years of experience 
in the cognitive-behavioral treatment of childhood anxiety disorders (M = 19.38 years, 
SD = 4.24, range 15-25). Expert reviewers provided advice as to the face and content 
validity of the SEE-C. Expert reviewer feedback was aggregated and findings integrated 




Table 1. Iterative Process of Feedback 
 
Aggregation and Consensus 
 
Quantitatively: 




• Item statements will be aggregated as to theme and consensus (i.e., frequency) 
will be determined 






• 100% participant agreement on a single item with a Mean = 7 or disagreement 
with a Mean = 1 will be an item for editing  
• Participant agreement on a single item with a Mean = 5 or 6 or disagreement with 
a Mean = 2 or 3 will be an item considered for editing but additional reference to 
the literature and advisor consultation will determine and justify scale adjustments  




• Consensus statements on a single item endorsed by each reviewer (N = 8) will be 
considered an item for editing 
• Consensus statements on a single item endorsed by one to seven reviewers (N = 1 
to 7) will be considered for editing but additional reference to the literature and 





 Field testing. A sample of 24 child-parent dyads was recruited from the Child 
Anxiety Program (CAP) at the University of Rhode Island (URI).  Children ranged in age 
from 8 to 15 years (M = 9.9, SD = 1.93), with almost half the sample identifying as 
female (46%) and identified as White, non-Hispanic. Children were in the 2nd to the 10th 
grade, with more than half of the sample in the 3rd through the 6th grades. Additionally, 
29% reported having a 504 plan in school. Parent participants identified as biological 
parents, a mean age of 42.1 (SD = 5.67), predominantly female (83%), and identified as 
White, non-Hispanic. The majority of children had biological parents living together 
(92%) and an average annual income ranging from $100,000-$120,000.  More than half 
of parents reported a college degree or higher (92%). See Table 2 for an outline of 
demographic information.  
 Retention rates. Twenty-four parent-child dyads consented to the field testing 
portion of the study. Out of the 24 dyads, one child decided they no longer wanted to 
complete study measures during the 1st session; however, the parent continued in the 
study. At mid- and post-treatment, study retention rates remained the same, with 23 child 






Table 2. Sample Characteristics (N = 24 Child-Parent Dyads) 
Child Gender  n (%)  
     Female 11 (46) 
     Male 13 (54) 
Child Age M (SD) 9.9 (1.93) 
Child Race  n (%)  
     White  24 (100) 
     Black/African American 0 
     Asian 0 
     American Indian/Alaskan Native 0 
     Native Hawaiian/Pacific Islander 0 
Child Non-Hispanic n (%) 24 (100) 
Child Grade n (%)  
     2nd Grade 1 (4) 
     3rd Grade 6 (25) 
     4th Grade 5 (21) 
     5th Grade 2 (8) 
     6th Grade 6 (25) 
     7th Grade 1 (4) 
     8th Grade 1 (4) 
     10th Grade 1 (4) 
Child 504 Plan (Details unspecified)  n (%) 7 (29) 
Family Annual Income n (%)  
      Under $20,000 0 
      $20,001 - $40,000 1 (4) 
      $40,001 - $60,000 2 (8) 
      $60001 - $80,000 0 
      $80,001 - $100,000 1 (4) 
      $100,001 - $120,000 6 (26) 
      $120,001 and over 12 (50) 
      Not endorsed/missing 2 (8) 
Child lives with n (%)  
     Bio mother and father 22 (92) 
     Bio mother  2 (8) 
Parent in study n (%)  
     Female 20 (83) 
     Male 4 (17) 
Parent Age M (SD) 42.1 (5.67) 
Parent Relationship to child n (%)  
     Biological Parent 24 (100) 
Parent Education Level n (%)  
     Some college  1 (4) 


























   
     Bachelors (BA, BS) 12 (50) 
     Masters 7 (30) 
     PhD 2 (8) 
     MD 1 (4) 
Parent Employment Status n (%)  
     Full-time 15 (62) 
     Part-time 4 (17) 
     Self-Employed 1 (4) 
     Not Employed 3 (13) 
     Prefer not to answer 1 (4) 
Parent Martial Status n (%)  
     Married 22 (92) 
     Divorced 1 (4) 
     Did not answer 1 (4) 
Parent Anxiety Disorder n (%)  
     Yes (past and/or current) 10 (42) 
     No 14 (58) 
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 All child participants met criteria for at least one anxiety disorder.  Eighty-six 
percent of the children met criteria for more than one disorder (anxiety or another type), 
ranging from two to five (M = 2.58, SD = 1.06) comorbid disorders. Primary anxiety 
diagnoses at pre-treatment included Generalized Anxiety Disorder (34%), Specific 
Phobia (23%), Separation Anxiety Disorder (14%), and Social Anxiety Disorder (14%). 






















 Frequency of Pre-Treatment Comorbid Diagnoses 
 
Diagnosis Pre-Treatment 
Separation Anxiety Disorder 9 
Generalized Anxiety Disorder 22 
Social Anxiety Disorder 9 
Specific Phobia 15 
School Refusal 1 
Misophonia 1 
Obsessive Compulsive Disorder 2 
Depressive Disorder 1 
Attention Deficit Hyperactivity Disorder 2 
Oppositional Defiant Disorder 1 
Panic 1 
None 0 
Diagnoses Count Pre-Treatment 
0 Diagnoses 0 
1 Diagnosis 3 
2 Diagnoses 8 
3 Diagnoses 9 
4 Diagnoses 3 





 The first two participants of the 24 child-parent dyads enrolled were queried after 
their completion of the SEE-C to glean information for response process validity. Two 
child participants (M = 12 years; Male = 2) were queried about their experience and 
understanding completing the SEE-C including the scale’s directions, questions, and 
response items. Both child participants identified as White, non-Hispanic. Response 
process feedback was aggregated and findings integrated. 
 Inclusion Criteria for the study were the following: 1) primary diagnosis of an 
anxiety disorder using the Anxiety Disorder Interview Schedule – IV (ADIS-IV; 
Silverman & Albano, 1996), adapted for DSM 5, 2) Child is between the ages of 8 and 17 
years old and has a parent or legal guardian available to participate in treatment, and 3) 
Child participant and parent are English speaking. Exclusion Criteria included a 
documented child diagnosis of Psychosis, Autism, or Intellectual Disability and child use 
of anti-depressant and/or anti-anxiety medications that has not been stable for more than 
six weeks. Exclusion criteria were designed to be minimal and exclude only those 
patients for whom CBT is not likely to be beneficial or may be risky.    
Measures 
 Expert reviewer questionnaires were completed and edits to the developed 
measure were made in prep for field testing. Field testing questionnaires were completed 
at pre-treatment, mid-treatment (after completing 8 weeks of CBT and prior to initiation 
of exposure practice), and post-treatment (session 16). All field testing questionnaires 
were completed during scheduled intake or therapy sessions. See Appendix A for table of 
administration time points. 
Self-Efficacy During Exposure – Child (SEE-C). The SEE-C is a 9-item, child 
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(ages 8 to 17 years old) self-report measure of perceived state self-efficacy during 
exposure using a 5-point Likert scale from 1 (“Not sure at all”) to 5 (“Completely sure”). 
Total scores range from 0 to 45, and higher numbers on total score indicate greater 
perceived self-efficacy. Three subscales were defined in the construction of this measure: 
‘success of handling distress during an exposure’ (items 1, 2, and 3), ‘success of 
individual exposures themselves’ (items 4, 5, and 6), and ‘success of exposure treatment’ 
(items 7, 8, and 9). Items were selected following Bandura’s (2006) recommendations for 
constructing scales of self-efficacy. Specifically, items were identified that had 
reasonable face validity, were developmentally relevant to the target sample, and had 
lower demand characteristics. Items were selected to incorporate a range of domains 
relevant to children with anxiety and to yield a total perceived self-efficacy score and 
subscales. See Appendix B for the original version of the measure (prior to edits via 
expert reviewer and participant feedback) and Appendix C for the final edited version.   
 An identical parent version of the measure was developed, where parents reported 
their perception of their child’s state self-efficacy during exposure. The parent version 
was created to corroborate the child version, as a method to assist with the validity of the 
child measure.  
Expert Reviewer Questionnaires 
 Clinician Demographic Questionnaire (CDQ). The CDQ was completed by 
expert clinicians (e.g., gender, education, institution). This information was used in 
preliminary descriptive analyses to describe the expert clinician sample. See Appendix D. 
 Clinician Feedback Survey (CFS). The CFS was adapted from the Pediatric 
Motivation Scale Service Provider Survey (Tatla, 2014) and used to obtain feedback from 
expert clinicians upon review of the SEE-C. Questions on this survey include Likert scale 
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and open-ended questions related to the measure’s face validity, clarity (i.e., conciseness, 
grammar, readability, layout, reading level, and redundancy of questions) and clinical 
utility (i.e., ease of administration, time to administer, and challenges in use). To 
corroborate findings, information was reviewed qualitatively and quantitatively and then 
aggregated to revise and refine the SEE-C. See Appendix D. 
 Semi-structured Administration Questionnaire (SSAQ). The SSAQ was 
adapted from the Administration Questionnaire (Tatla, 2014). This questionnaire was 
used to query child/adolescent participants about their experience completing the SEE-C. 
Child/adolescent participants were asked about their understanding of the scale’s 
directions, questions, and response items. They were asked to provide any comments they 
have in regards to each. To corroborate findings, queried information was summarized 
and aggregated to revise and refine the SEE-C. See Appendix D. 
Field Testing Questionnaires 
 Caregiver Demographics. This demographics questionnaire was completed by 
parents at baseline and includes questions regarding family composition, parent 
information (e.g., age, gender, race, ethnicity, education, income, occupation), and child 
information (e.g., age, gender, race, ethnicity, education). See Appendix D. 
 Anxiety Disorder Interview Schedule for Children for DSM-IV (ADIS-IV), 
adapted for DSM 5 (American Psychiatric Association (APA), 2013). The ADIS-IV 
(Silverman & Albano, 1996), a structured diagnostic interview for children (ages 7 – 17 
years) is based on the Diagnostic Statistical Manual-IV (DMS-IV; American Psychiatric 
Association (APA), 2000), was adapted to correspond to DSM 5 diagnoses. Parent and 
children were interviewed separately using the ADIS, and reports were combined to form 
consensus diagnoses. The ADIS-IV (adapted for DSM-5) was used to determine study 
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inclusion criteria related to child/adolescent diagnoses. Graduate student clinicians 
demonstrated a strong interrater reliability on the ADIS, Cohen’s kappa > or = .6) before 
participating in the present study (ADIS; DiNardo et al., 1994). 
 Spence Children’s Anxiety Scale (SCAS). The SCAS (Spence, 1997; child and 
parent versions) is a 38-item measure of a child’s anxiety. Scoring includes an overall 
(total score) of anxiety that is made up of six subscales (separation anxiety, social phobia, 
obsessive-compulsive disorder, physical injury fears, generalized anxiety, 
panic/agoraphobia) each tapping a specific aspect of child anxiety utilizing a four-point 
scale of how often things occur: 0 = never, 1 = sometimes, 2 = often, or 3 = always. The 
greater the score, the more anxiety symptoms present. In this sample, both the child and 
parent versions of the SCAS demonstrated good reliability (α = .884; α = .853, 
respectively).  
 Child Sheehan Disability Scale for Anxiety (CSDS). The CSDS (Whiteside, 
2009) is a 3-item measure assessing impairment in child functioning related to anxiety 
and has excellent psychometric properties. Increased composite score indicates greater 
impairment.  
 Clinical Global Impression (CGI). The CGI (Guy, 1976) is a 2-item, 7-point 
scale measuring clinician-rated client severity (0 = Not assessed to 7 = Among the most 
extremely ill patients) and improvement (0 = Not assessed to 7 = Very much worse) 
during treatment. An increase in clinician ratings denotes worsening symptoms for both 
scales. 
 Pediatric Motivation Scale (PMOT). The PMOT (Tatla, Jarus, Virji-Babul, & 
Holsti, 2015) is a 19-item, child self-report measure that examines a child’s (8 to 19 
years) perceived motivation during therapy. Items are rated on a scale from 0 (Not true at 
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all true) to 5 (Definitely true). Average total score indicates child’s overall state 
motivation with higher scores indicating greater state motivation. This measure 
demonstrated good reliability in this sample (α = .815). 
Procedure    
 Internal Review Board (IRB) approval was granted through the University of 
Rhode Island.  
 Expert review. Expert reviewers were identified from the extant literature based 
on their expertise on anxiety disorders in children and adolescents. A list of twenty-one 
experts was identified and contacted to determine their interest in participating in the 
study. Confirmation of their areas of expertise and relevant experience was solicited as 
study inclusionary criteria. After informed consent was obtained, each expert reviewer 
was asked to complete the Clinician Demographic Questionnaire and was provided a 
summary of findings on the self-efficacy for exposure review of the literature to provide 
current information justifying the measure development. Then, expert reviewers were 
provided directions on the administration of the SEE-C and asked to complete the 
Clinician Feedback Survey.  
 Field testing. Recruitment efforts focused on parents and children seeking 
treatment at the University of Rhode Island (URI)’s Psychological Consultation Clinic’s 
(PCC) Child Anxiety Program (CAP). In tandem with the CAP clinic procedures, a short 
phone screen by the PCC coordinator was used to identify potentially eligible 
participants. The research study was introduced to families at this time and interested 
parents were provided a short description of the study and an opportunity to ask 
questions. Consistent with the CAP clinic procedures, eligible families were invited to the 
clinic for a two-hour visit during which an intake assessment occurred.  
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 Informed parent consent and child assent for the present study was conducted 
during the intake following the usual treatment consenting procedures for CAP. Families 
were reminded that study participation was voluntary and could be discontinued at any 
point during their treatment and the termination of their participation would not affect 
their treatment status.  
 Following informed consent/assent, pre-treatment assessments were administered 
with the parent and child. Families not interested in participating in the study were not 
penalized and were free to continue with treatment in CAP, provided they met with entry 
requirements specific to the CAP program. Families who agreed to participate in the 
present study were provided a complementary treatment manual (value ~$25) as 
compensation for their participation. The consent, assessment, and treatment procedures 
were video recorded (as consistent with CAP procedures) to ensure accuracy of 
procedures, and videotapes were destroyed in alignment with APA, Health Insurance 
Portability and Accountability Act (HIPAA), and PCC requirements.  
Child participant reviewers. The first two participants of the 24 child-parent 
dyads recruited were queried about their experience completing the SEE-C using the 
SSAQ. Participants’ response processes was observed and recorded while they complete 
the SEE-C pre-session. Research staff queried on items from the SEE-C that seemed 
difficult to answer or appeared confusing to participants. Participants were also asked to 
explain the rationale for their response selections to further evaluate participants’ 
understanding of the SEE-C items. In order to minimize the effects of social desirability, 
a study research assistant administered the scale to the child, and the treating therapist 
was not present. Information gleaned on the SSAQ was reviewed quantitatively and 
qualitatively and then used to revise and refine the SEE-C. 
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 Treatment. The treatment provided was CBT with exposure per the 16-session 
Coping Cat treatment protocol (Kendall & Hedtke, 2006) and involved coping skill 
instruction and practice to reduce anxiety. Length of treatment sessions was 50 minutes.  
At each session, child and parent participants completed paper and pencil measures about 
child perceived self-efficacy and motivation. At mid- and post-treatment, participants 









 Preliminary statistical analyses. All statistical analyses were conducted using 
IBM SPSS Statistics version 24 (IBM Corp., 2016). Data were cleaned (frequencies, 
means, standard deviations and ranges were examined) and scored, and tests of 
assumption and normality for skewness and kurtosis were completed. Overall, study 
measures were deemed normally distributed (See Table 4). Descriptive statistics were 
used to summarize the sample characteristics. Continuous variables were summarized 
using means and standard deviations. Categorical variables were described with 
frequencies and percentages. Pre-treatment report of child prescribed anxiety medication 
(n = 2; Zoloft and Lorazepam) versus no medication were examined and showed no 
significant differences on the SEE-C child version or anxiety symptom measures; as a 
result, medication usage was not controlled for in the overall study analyses. Consistent 
with an intent-to-treat approach, all participants were included in the data analyses.  
 Missing data. Utilizing maximum likelihood, expectation–maximization 
algorithm (Allison, 2012), missing outcome data on randomly assigned participants were 
replaced. A nonsignificant Little’s Missing Completely At Random (MCAR) test 
suggests that the data were missing completely at random (Little, 1988). Maximum 
likelihood imputation, using the expectation–maximization algorithm, was used to impute 
the missing data (less than 5%) to improve statistical power with unbiased parameter 
estimates (Enders, 2001; Scheffer, 2002). Missing data were imputed using the Missing 
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Values Analysis (normal distribution; 25 iterations) within SPSS 24.0 (IBM, 2016).  
 Iterative feedback process. Expert review and child participant feedback assisted 
in the established preliminary psychometrics of the SEE-C via evaluation of the 
following forms of validity: 1) content validity, as demonstrated by a review of self-
efficacy measures in the literature and expert review of the SEE-C; 2) face validity, 
informed by expert review and field testing; and 3) response processing, determined by 
child participant feedback during field testing. In addition, reliability was assessed after 
field testing the SEE-C by examining internal consistency in the evaluation of 
correlations between different items on the same test. 
 Expert reviewer and child participant feedback was integrated per outlined 
considerations (including both quantitative and qualitative methods, which are outlined in 
Table 1) and literature review.  Item responses were summarized descriptively using 
frequencies, means, and standard deviations and evaluated qualitatively through an 
























1 to 5 Higher: More 
self-efficacy 
45 21-44 33.26 5.62 -.264 -.186 
SEE-C 
Parent, n=22 
1 to 5 Higher: More 
self-efficacy 
45 20-41 28.45 5.31 .317 -.100 
PMOT, n=22 0 to 5 Higher: More 
motivation 
95 66-95 81.18 8.91 .068 -.672 
Spence Child, 
n=24 
0 to 3 Higher: More 
symptoms 
114 6-62 34.29 14.72 .173 -.686 
Spence 
Parent, n=24 
0 to 3 Higher: More 
symptoms 




0 to 10 Higher: 
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0 to 10 Higher: 
Greater 
impairment 
10 0-9 4.67 3.07 -.127 -1.495 
CGI Severity, 
n=24 
0 to 7 Higher: More 
severe 




0 to 7 Higher: Less 
improvement 






 Tailoring the SEE-C per expert review. A sample of eight expert reviewers 
were recruited to tailor the SEE-C to the age and population of the proposed sample with 
emphasis on content and face validity. The CFS was used to obtain feedback on the 
measure’s face validity, clarity, and potential clinical utility.  
 Responses on the CFS were reviewed, summarized, and aggregated for 
incremental integration of the best representation of the construct of self-efficacy, ease 
and clarity of reading the instructions for the scale, ease and clarity of reading the scale, 
layout attractiveness, appropriateness of reading level appropriate for those as young as 8 
years old, and ease of completion by children/adolescents. See Table 5 for summary of 
CFS responses. 
 The CFS revealed that >50% of the expert reviewers thought the results of the 
SEE-C would inform their intervention planning and treatment engagement during 
exposure, the SEE-C items represented self-efficacy, and that youth with anxiety could 
understand responses. More specifically, 50% “agreed” or “strongly agreed” that items 
represented self-efficacy; 75% “agree” to “strongly agree” instructions were easy to 
follow; 62% “agree” to “strongly agree” youth with anxiety could understand responses; 
87.5% thought the layout of questions was attractive and appealing; 62.5% “somewhat 
agree” and 25% “agree” reading level of SEE-C is appropriate for an 8-year old child; 
100% “agree” to “strongly agree” a child with anxiety would not object to answering any 
items on the SEE-C;  50% endorsed “<5 minutes” and the other 50% “5-10 minutes” 
regarding how long they thought it would take to complete SEE-C; 100% thought “5-10 
questions” was a reasonable number of questions to include on the SEE-C. Reviewers 
indicated the measure results would inform intervention planning and treatment 
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engagement during exposure with 62.5% responding “yes,” 25% “possibly,” and 12.5% 
left the question blank. Sixty-two percent believed this scale would be helpful to them as 
a therapist. Thirty-seven percent believed that it might be useful.  See Figure 2 for a 




Table 5. Expert Reviewer Feedback 
 
Question prompt:  
Q.) “In your opinion, would this scale be helpful to you as a therapist?” 
 Responses: 
 “Yes”  = 5 (62.5%);   “Maybe” = 3 (37.5%);   “No”  = 0 (0%) 
 
If you answered “Yes” to Q., explain how this scale could be helpful to you:  
Predict Better Treatment Outcomes: 
“Good to prompt and guide clinical discussion about areas where there is less self-
efficacy and may be able to predict outcome” 
 
“Towards end of treatment, it would give therapist another source of ERP efficacy & 
possibly predict treatment outcomes and maintenance of treatment gains” 
 
Fill an Important Niche: 
“I agree with you, the Child Self-Efficacy is not adequately assessed in CBT and this 
would fill an important niche. Especially, if it is given as a repeated measure across 
treatment to assess treatment-related changes in children's confidence. Nice job.” 
 
Self-efficacy may be a Mechanism of Anxiety Reduction: 
“If change in self-efficacy cognitions are a mechanism of anxiety reduction, this measure 
may help test this hypothesis” 
 
Assist with Engagement During Exposure: 
“It might be helpful by providing a structured way to assess for the nuances associated 
with the child's thoughts/beliefs about exposure tasks” 
 
“It would help at beginning of treatment to assess a patient’s expectations about ERP and 
allow the therapist to provide psychoeducation to enhance acceptability of treatment”  
 
“Specifying child's belief in his/her efficacy can then become a target for intervention 
(e.g., self-talk)” 
 
“Yes, because you can assess expectations (in items 7-9) & attributions (in items 4-5)” 
  
If you answered “Maybe,” explain how this scale may or may not be helpful to you: 
“I am somewhat concerned that many of the items have to do more with outcome 
expectancy and other constructs that are related to self-efficacy but are not really self-
efficacy” 
 
“I just wonder if children can rate their response to exposures in general. They may say 







Figure 2. Expert Reviewer Feedback 
 
Thought the SEE-C Child would be helpful to them as a therapist:  
62.5% = “yes” and 37.5% = “maybe” 
	
	
If “Yes,” explain how this scale could be helpful to you:  
•  Predict better treatment outcomes 
•  Fill an important niche 
•  Self-efficacy may be a mechanism of anxiety reduction 
•  Assist with engagement during exposure 
 
Thought the SEE-C Child would inform intervention planning and treatment 




Thought the SEE-C Child items represented self-efficacy:  
12.5% = “strongly agree,” 37.5% =“agree,” and 25% = “somewhat agree” 
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SEE-C response processing per child feedback. The SSAQ was used with two 
child participants to elicit qualitative and quantitative feedback on the comprehension of 
scale items and the understanding of response format. This information was used to 
revise and refine the SEE-C. Both child participants described the developing measure as 
needing more information regarding the definition and examples of exposure. Then, once 
the SEE-C was revised and the additional information included, child participants 
reported that the questionnaire was easy to understand and both required minimal 
assistance to complete the questionnaire. They also indicated that they would willingly 
complete the SEE-C, the questions were easy to answer, and they liked the formatting of 
the responses. The SEE-C was edited via a formal iterative process with regard to age-
level readability, conciseness, and the need to add a definition and example of exposures.  
Field Testing  
 Sample characteristics. A clinical sample of 24 treatment-seeking parent-child 
dyads was enrolled into the study. One-way ANOVA’s were conducted on the number of 
pre-treatment comorbid diagnoses (ranging from 1 to 5 diagnoses) by pre-, mid-, and 
post-treatment on the child’s self-report of self-efficacy on the SEE-C. Due to the low 
frequency of four (n = 3) and five (n = 1) diagnoses, these two values were collapsed to 
one value (n = 4) for these analyses. Results indicated no difference in self-efficacy at 
pre- and mid-treatment on the SEE-C child version; however, a significant difference on 
child self-efficacy was seen at post-treatment by the number of pre-treatment comorbid 
diagnoses (F(3,19) = 3.260, p=.044), where post hoc test revealed a difference 
approaching significance (p = .056) between a comorbidity of two pre-treatment 
diagnoses (n = 8) and four/five diagnoses (n = 4).See Table 6 for post-treatment 
diagnoses frequencies and treatment counts.
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Frequency of Post-Treatment Comorbid Diagnoses 
 
Diagnosis Post-Treatment 
Separation Anxiety Disorder 0 
Generalized Anxiety Disorder 8 
Social Anxiety Disorder 2 
Specific Phobia 2 
School Refusal 1 
Misophonia 0 
Obsessive Compulsive Disorder 1 
Depressive Disorder 1 
Attention Deficit Hyperactivity Disorder 1 
Oppositional Defiant Disorder 1 
Panic 0 
None 12 
Diagnoses Count Post-Treatment 
0 Diagnoses 12 
1 Diagnosis 10 
2 Diagnoses 1 
3 Diagnoses 0 
4 Diagnoses 1 




Examination of the SEE-C at Pre-treatment  
 Bivariate Pearson Correlation Coefficients were run between the pre-treatment 
measures including the SEE-C, SCAS, CSDS composite scores and demographic 
variables (child age and gender). Results showed that the SEE-C was significantly related 
to parent report of child anxiety symptoms as measured by the SCAS (r = -.417, p = 
.048). The parent and child report of anxiety symptoms were also significant and 
positively correlated to each other (r = .715, p = .000). In addition, significant 
relationships were found between the child report of anxiety symptoms and the child 
report of functional impairment within the family (r = .502, p = .017), the parent report of 
child functional impairment socially (r = .625, p = .001), and the parent report of child 
functional impairment within the family (r = .688, p = .000). The child report of anxiety 
symptoms was also significantly related to the clinician report of symptom severity on 
the CGI (r =. 477, p = .018). See Table 6 for complete list of pre-treatment correlations. 
 Given the significant pre-treatment relationship between the SEE-C child version 
and the SCAS parent version, as well as other pre-treatment measures, regression 
analyses were conducted to examine whether the child symptoms of anxiety, functional 
impairment, and motivation predicted to child self-efficacy. The first regression model 
examined whether parent report and child self-report of pre-treatment anxiety symptoms 
predicted child self-report of self-efficacy. Results approached significance, R2 = .232, 
F(2, 22) = 3.019, p = .071, where only the parent report of child anxiety symptoms was 
significantly predictive (β = -.646,  t = -2.389, p = .027). Three additional regression 
analyses examining (1) child self-report of state motivation, (2) child self-report and 
parent report of child functioning, and (3) clinician report of child symptom severity and 
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improvement as well as child age and gender as predictors of child self-report of self-
efficacy were not significant.  
 Internal consistency of the SEE-C child version ranged from acceptable to 
excellent at pre-, mid-, and post-treatment (Cronbach’s alphas of 793, .848, and .901, 
respectively). Similarly, the SEE-C parent version demonstrated good to excellent 
reliability, with Cronbach’s alphas of .874 at pre- treatment, .932 at mid- treatment, and 
.901 at post-treatment. 
 Given the good pre-treatment internal consistency of the SEE-C child version as 
one single dimension, an exploratory principle component analysis (PCA) using Varimax 
rotation was performed on the 9-item scale to determine the underlying factor structure. 
A three-factor solution, with loadings ranging from 0.5 to 0.9, emerged from the analysis. 
Item one did not clearly load on a single factor but overlapped on two (Factor 1, ‘belief in 
success of handling distress during an exposure,’ and Factor 3, ‘belief in success of 
exposure treatment’). Items two, three, and four loaded on Factor 1 (‘belief in success of 
handling distress during an exposure’); items five, six, and nine loaded on Factor 2 
(‘belief in success of individual exposures themselves’); and items seven and eight loaded 
on Factor 3 (‘belief in success of exposure treatment’). Cronbach alphas for each factor 
showed promising results with acceptable to good internal consistency, as Factor 1 had an 
α =. 748, Factor 2 had anα = 708, and Factor 3 had an α = .831 (item one was 
eliminated from these analyses due to the overlap between two factors). While three 
meaningful constructs are suggested, no clear determination of factor loadings can be 





Examination of the SEE-C at Mid- and Post-Treatment 
  An exploratory examination at both mid- and post-treatment of the relationship 
between parent and child report of child anxiety symptoms, functioning, and clinician 
report of symptom severity and improvement were conducted (See Tables 7 & 8). 
Specifically, at mid-treatment, clinician report of child symptom severity was negatively 
correlated to child self-report of self-efficacy (r = -.603, p = .003). At post-treatment, 
child self-report of self-efficacy was inversely related to child self-report of anxiety 
symptoms (r = -.611, p = .004), parent report of child anxiety symptoms (r =   -.545, p = 
.016), parent report of child functioning within the family (r = -.605, p = .006), and 
positively correlated to both parent report of child self-efficacy (r = .484, p = .023) and 



















 Due to significant relationships at mid-treatment and at post-treatment between 
the SEE-C and other constructs, hierarchical multiple regressions were performed to 
assess whether certain variables predicted to lower child anxiety symptoms at mid-
treatment and at post-treatment. Significant results were seen when modeling post-
treatment child self-report of self-efficacy on the SEE-C and PMOT (motivation) and 
predicting to post-treatment child self-report of anxiety symptoms via the SCAS after 
controlling for pre-treatment child self-report of anxiety symptoms, self-efficacy, and 
motivation. Results demonstrated that there was a significant effect (F(5, 13) = 4.348, 
p = .015, R2 = .626), where, after controlling for pre-treatment variables, at post-
treatment higher child-report of self-efficacy predicted to lower anxiety symptoms via 
child-report (β = -.574, p = .013). Individual predictors were examined and are 
reported in Table 9. 
Evaluation of the SEE-C Overtime  
 Repeated measures MANOVAs were conducted on all measures and groups of 
measures with the same construct (i.e., child self-efficacy, child anxiety symptoms, 
child motivation, and child functioning) across pre-, mid-, and post-treatment. 
Significant differences were seen overtime on most constructs. Particularly, findings 
showed that the SEE-C child and parent versions demonstrated significant, large 
effects from pre-, to mid-, to post-treatment (F(2, 18) = 7.976, p = .000, ηp2 = .301). 
Bonferroni post hoc tests showed that participants experienced a significant change on 
the child version, p = .044, from pre-treatment to mid-treatment and on the parent 
version with significant increases from pre- to post-treatment (p = .017), mid- to post-
treatment (p = .010), and pre- to post-treatment (p = .000). See Figure 3. The child and 
parent anxiety symptoms measures (See Figure 4) also showed large effects and 
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significant differences overtime, F(2, 17) = 10.845, p = .000, ηp2 = .383. Post hoc tests 
revealed that the parent report demonstrated significant decreases in anxiety symptoms 
over time: pre- to post-treatment (p = .023), mid- to post-treatment (p = .000), and pre- 
to post-treatment (p = .000).  
 Additionally, child and parent functional impairment measures as well as the 
clinician ratings measures also demonstrated significant change across time, with 
medium to large effect sizes. For instance, parent and child report of child social 
impairment (See Figure 5) was significant overtime with a medium effect size, F(1, 
17) = 3.146, p = .020, ηp2 = .160. Post hoc tests showed significant mean difference 
between pre- to post-treatment, where social function increased overtime (p = .012). 
Similarly, with a medium effect size, parent and child report of child impairment (See 
Figure 6) within the family was significant overtime (F(1, 17) = 3.190, p = .019, ηp2 = 
.162), with post hoc differences seen from pre- to post-treatment (p = .008), showing 
an increase in child functioning within the family. Finally, a large effect size and 
significant difference overtime was seen on the clinician rating (See Figure 7) of child 
symptom severity and improvement (F(2, 21) = 9.963, p = .000, ηp2 = .317). Clinician 
report on child symptom severity demonstrated significant differences (decreases) 
between pre- to post-treatment (p = .000) and mid- to post-treatment (p = .001), and on 
child improvement (increased in improvement) between pre- to post-treatment (p = 
.003) and mid- to post-treatment (p = .000). See Table 10 for a complete list of 



















































 This study fills a gap in the literature with the development, preliminary 
psychometric evaluation of reliability and validity, and field testing of a questionnaire of 
child self-efficacy to be used during exposure in CBT for pediatric anxiety disorders. The 
purpose of developing the SEE-C was to facilitate the understanding of child/adolescent 
factors that contribute to treatment engagement during exposure. Overall, the SEE-C 
child version was found to be helpful to therapists, particularly during treatment planning 
and engagement during exposure. It demonstrated good face and content validity, 
acceptable to excellent internal consistency/reliability from pre-treatment to post-
treatment on the measure as a whole, and a promising three-factor structure that 
demonstrated acceptable to good internal consistency per factor. 
 Much of the literature on child anxiety treatment focuses on treatment outcomes 
of CBT with exposure but not on the effects of child engagement during exposure. Child 
factors that may influence this engagement, as postulated in the theory of positive 
psychological momentum, include perceived self-efficacy and motivation. As study 
findings suggest, self-efficacy and motivation are relevant and important to child 
engagement during exposure, as they predicted to reduced anxiety symptoms at post-
treatment.  Additionally, child self-efficacy was significantly related to child anxiety 
symptoms, child symptom severity, and level of child functioning within the family at 





 This clinical sample of treatment-seeking parents and youth, while consistent with 
previous research on many demographic characteristics, demonstrated at pre-treatment 
that greater than half of the youth met criteria for multiple diagnoses of anxiety disorders 
as well as other disorders. Specifically, 71% of the sample received at least two or three 
concurrent diagnoses determined via a semi-structure assessment (ADIS-IV revised for 
DMS-5 (APA, 2013)). Further, post-treatment outcomes indicated that 50% of children 
ended treatment with no diagnoses and another 42% met criteria for only one diagnosis 
(80% of which was a single anxiety disorder diagnosis). These statistics mirror diagnoses 
rates in other studies focused on CBT for pediatric anxiety disorders (i.e., Cartwright-
Hatton et al., 2006).  
This study’s focus is novel in its examination of self-efficacy as a factor 
postulated to contribute to engagement during exposure and assist in explaining ‘why’ 
children engage in exposure. When considering the comorbid diagnoses, it seems that the 
compounded symptom presentations would dampen the treatment outcomes seen in this 
study; however, they did not.  Interestingly, among this small clinical sample, child self-
efficacy did not differ according to comorbidity (presence/absence) at pre- and mid-
treatment. However, significant differences in post-treatment child self-efficacy were 
found between those children who had two diagnoses versus those with four to five 
diagnoses in that those with greater comorbidity showed less perceived self-efficacy than 
those with fewer diagnoses at the end of treatment.  
The SEE-C: Psychometric Evaluation  
 Expert reviewer and youth feedback indicated that the SEE-C child version 
showed acceptable and appropriate face and content validity. The measure was found to 
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be adequate in design and content for the age and population under study. The measure 
also subjectively appeared to measure the construct it was supposed to measure. For 
example, expert reviewers indicated an interest in the creation of the SEE-C as a tool to 
address a child’s in-session beliefs about self-efficacy during exposure practice. Expert 
reviews were also positive about the SEE-C’s ability to measure one of the child factors, 
i.e., self-efficacy, that is likely to improve treatment engagement during exposure and 
resultant treatment outcomes.    
 Because of the acceptable to excellent internal consistency for the measure as a 
whole, exploratory PCA with Verimax rotation was utilized and suggested a three-factor 
structure. These three factors appear relevant to the measure, and the results are 
promising, as future confirmation of the factor structure (i.e., subscales) may better 
explain the results of a child’s self-efficacy overtime, therefore providing greater 
information as to a child’s engagement during exposure. For instance, in this pilot study, 
the child-report of self-efficacy demonstrated a significant increase from pre- to mid-
treatment; however, it then slightly reduced from mid- to post-treatment (although still 
significantly increased from pre-treatment). While these results are interesting, the reason 
for the increase and slight decrease can only be inferred. Where as, if we were able to 
utilize the measure’s subscales, we could better explain a child’s perceived self-efficacy 
overtime via the more concise definition of each subscale, as each of the factors would 
explain a unique component of the child’s self-efficacy.  
 In addition, there was significant positive association and medium effect size 
between the SEE-C child version and the SEE-C parent version at post-treatment. While 
is does not provide evidence of construct validity (the degree to which a measure 
adequately evaluates the construct it claims to assess), since both measures are newly 
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created, it does further assist in supporting the face and content validity. This is observed 
as both the parent and the child responder appeared to understand and be able to report on 
perceived child self-efficacy during exposure. While there is no simple metric to quantify 
this measure’s construct validity (Westen & Rosenthal, 2003), particularly because this 
appears to be the first to measure self-efficacy in CBT for pediatric anxiety, correlations 
between the SEE-C child version and measures of child anxiety symptoms and 
functioning demonstrate relationships in directions expected in a measure of self-
efficacy. For example, there was a negative association and large effect size of reported 
child anxiety symptoms with child self-reported self-efficacy as well as another negative 
correlation and large effect size between child functioning and child self-reported self-
efficacy.  
Engagement During Exposure  
 In order for CBT with exposure to be effective, exposures must be completed, as 
exposures are one of the main or “active” ingredients in CBT for pediatric anxiety 
disorders (Hudson & Kendall, 2002). As such, a focus on the engagement during 
exposure practice is necessary. Engagement is not always easy, as it involves multiple 
components including a motivational commitment and behavioral involvement and a 
child’s participation, therapist and child collaboration, and the child’s belief of self-
efficacy to continue in the agreed-upon and identified intervention (King, et al., 2014). 
Additionally, and as stated earlier, Positive Psychological Momentum (PPM) is the 
“perception, attitude, belief, or state-of-mind an individual experiences, in which their 
initial success leads to more successes” (Iso-Ahola & Blanchard, 1986). So, the hope is 
that once a child feels self-efficacious in completing a task competently multiple times 
(such as exposures), he/she will become confident in their abilities. As a result, a child’s 
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in-session self-efficacy and motivation to experience and feel distress in the face of a 
feared stimulus may be one of the important ingredients in the engagement in exposure 
practice.  
 Perceived self-efficacy and motivation. Study findings indicate that child 
perceived self-efficacy is negatively related to child anxiety symptoms over time (pre-, 
mid-, and post-treatment), whereby when a child’s perceived self-efficacy is low, their 
anxiety symptoms are high. Furthermore, as treatment progresses, a child’s self-efficacy 
increases and their anxiety symptoms decrease. This is also true in the relationship 
between child perceived self-efficacy and symptom severity as well as functional 
impairment (social, school, and family domains). These findings provide evidence into 
one, seemingly impactful, factor that contributes to a child’s engagement during 
exposure. 
 This study’s goal was to define child factors that contribute to engagement in 
exposure, including the perceived self-efficacy and motivation a child believes he/she has 
and uses to incrementally approach a feared situation/event.  However, by identifying 
factors that influence engagement, we also need to consider that these factors under 
investigation may be stimulated by the anxiety (the “challenge”) that maintains the 
momentum to generate self-efficacy and motivation. Once a “challenge” is conquered, 
another “cycle” of momentum needs to be generated to deal with the next challenge. 
Depending on the child, it may take some time to build the stamina needed to wade 
through potentially multiple challenges presented by anxiety. A focus on additional child 
factors of engagement during exposure are outside the scope of this current study; 
however, the consideration of these additional factors is necessary and leads us to the 
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future directions of this research, as well as highlights the importance of and need to 
consider parent and therapist factors that may exist. 
Limitations 
 While this study has multiple strengths, it does not go without limitations. Expert 
reviewers reviewed the measure only once rather than multiple times through an iterative 
feedback process. While an iterative process would have provided more feedback 
regarding the edited measure’s face validity, a consensus regarding the measure’s clinical 
utility occurred with a singular review. This study was also limited by the child feedback 
portion of the study, as there was a small sample size of child reviewers (N=2) and no 
variation in gender and age. However, these were the first two recruited child participants 
into the study and defined by the research proposal to be the child feedback participants. 
Nonetheless, the child reviewers’ feedback was valuable and provided information on the 
developing measure in a structured interview after the measure was administered, and the 
children’s answers were queried in real-time. This feedback was thorough and 
qualitatively as well as quantitatively assisted in shaping the measure. Additionally, the 
homogeneity of the field testing sample makes the SEE-C non-generalizable to 
populations who are dissimilar. There was no control group for comparison. Future 
research should include a randomized control clinical trial. Study findings would be 
stronger if psychiatric diagnoses were assessed at post-treatment and if follow-up 
assessments were completed. In the present study, post-treatment diagnoses were 
determined by each treating clinician without the use of a structured diagnostic 
instrument.   
 In sum, the present study addresses a gap in the literature by developing a 
measure that identifies a child’s self-reported, perceived ability (i.e., self-efficacy) to 
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complete exposures during CBT for anxiety disorders. This research contributes to the 
understanding of child engagement during exposure in CBT for anxiety disorders and, 
thus, may help to improve treatment outcomes by calling attention to those factors 
influential in a child’s ability to make the most of exposures during CBT treatment. 
Necessary next steps are to further test and validate the developed measure. Once 
determined valid and reliable, future research could examine whether a child’s perceived 
in-session self-efficacy during exposure predicts to a child’s between-session self-
efficacy during exposure, as well as whether self-efficacy predicts a child’s motivation to 
do a greater amount and/or more difficult exposures during CBT for anxiety disorders 
over time.  
 Future directions for research include the need for a randomized controlled 
longitudinal study using the SEE-C, as well as an examination of other child factors 
likely to influence child engagement during exposure and, ultimately, procure improved 
treatment outcomes. In addition, a larger sample size would assist in greater measurement 
testing and the confirmation of psychometric properties such as reliability of domain 
factor structure, test-retest reliability, and criterion related validity. Similarly, parent and 
clinician factors that influence engagement during exposure also need to be explored. For 
instance, parent factors to be examined include parent accommodation, knowledge about 
exposure and exposure practice, and parent perceived self-efficacy (or belief) about their 
child’s ability to complete exposures. Clinician factors worthy of study include 
clinicians’ beliefs about their client’s ability to complete exposure practice, knowledge of 
and ability to employ motivation enhancement techniques, rapport building skills, and 
skill and ability to individualize and create appropriate and effective exposures. 
Additionally, motivation and growth mindset are two areas that are important when 
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considering child factors that influence engagement during exposure that may, ultimately, 
contribute to better treatment outcomes. For example, motivation is important for 
ongoing behavior change during psychotherapy and has been documented to improve 
efficacy in treatment of anxiety disorders, obsessive-compulsive disorders, depression, 
and substance use (e.g., Cox, Blount, Bair, & Hosier, 2000; DiClemente, 1999; 
Lombardi, Button, & Westra, 2014; Ponzini, Van Kirk, Schreck, Nota, Elias, 2019).  
 The area of growth mindset is equally important to consider as a child factor 
influencing engagement during exposure. Growth mindset is based on the belief that 
basic trait qualities are things you can cultivate and grow through your efforts because 
they are malleable - not fixed (Dweck, 2008). Utilizing this mindset, one can conceivably 
challenge themself to try something new and learn from it, just by sticking with it, even 
when it is difficult (as in the case of exposure practice during the treatment for anxiety 
disorders; Dweck, 2016). Research on growth mindset and anxiety has been 
demonstrated and shows promising results (e.g., Schleider & Weisz, 2018). As such, 
more research is needed to continue to explore this factor.  
To conclude, CBT with exposure for childhood anxiety disorders is demonstrated 
effective in reducing child anxiety over time; however, it is not 100% effective. As such, 
research needs to identify the factors impacting child engagement during exposure to 
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Appendix B. Original version of the SEE-C Child 
Self-Efficacy during Exposure – Child version (SEE-C) 
 
Each question will ask you to tell how “sure you are” that you can do a certain thing 
during your exposure, and to provide an answer that best matches your feeling. 
Remember, an exposure is an agreed upon task or situation that allows you to practice 
facing your fears.  
 
 Practice items: If you were asked to do each of these things, how sure are you that you 
could:  
 
a) Jump into a cold pool of water…   
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
    0     1   2     3          4   
b) Eat a dessert of your choice…   
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
    0     1   2     3          4  
 
How sure are you that you can do each of the following things during an exposure?  
1. Stay in a scary or uncomfortable situation… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
    0     1   2     3          4  
 
2. Sit with a scared or uncomfortable feeling/emotion… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
    0     1   2     3          4  
 
3. Sit with a scary or uncomfortable thought… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
    0     1   2     3          4  
 
How sure are you that each of the following things will happen during an exposure? 
 
4. Your fear will go down, all on its own… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
   0     1   2     3          4  
  
5. You will be able to bring your fear down on your own… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
   0     1   2     3          4   
 
6. You will learn whether the thing you fear happens as you thought it would… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
   0     1   2     3          4    





How sure are you that each of the following things will happen in the future, after 
you work hard on many exposures? 
 
7. Exposures will help me be less afraid… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
   0     1   2     3          4  
  
8. Exposures will help keep my fears from getting in the way of the things I want to do… 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
   0     1   2     3          4   
 
9. Exposures will help me be stay less afraid after treatment is complete...  
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
   0     1   2     3          4    
 



































Appendix C. Edited version of the SEE-C 
ID #: __________ 
Date: _____________ 
SEE-C (Child version) 
 
 
For Therapist Only: In the blank below, please list one situation/object that the 
child has identified as scary or worrisome at a feelings thermometer rating of 4-6. 
Read the text in italics aloud to the child.  The child will then complete the 
remaining sections on his/her own. 
 
 
Today, I’m going to ask you some questions about things people do, and I’d like to know 
how “sure you are” that you can do them.  
 
 
For example: How sure are you that you could:  
 
a) Jump into a cold pool of water…   
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 
                              
 
b) Eat your favorite dessert…   
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure     Completely sure 




OK, great!  Now, I want to ask you how sure you are about doing some things during a 
practice task. A practice task is an activity a person does to be less afraid of something – 
like to be less afraid of a dog or bees or of the dark.  When people are afraid of 
something, they often try to stay away from it. Practice tasks slowly introduce a person to 
what they are afraid so they get used to it.   
 
For example, a practice task for a person who is afraid of spiders might be:  
 
• thinking about (or imagines) a picture of a spider  
OR 
• looking at a picture of a spider in a book  
OR 
• looking at a spider on the wall  
 
So remember, a practice task is an activity that slowly introduces a person to a 
situation/object that they are afraid of. 
 
You said earlier that you were afraid of ______________________________ (with a 
feelings thermometer rating of 4-6). Imagine, for these next questions, that you are being 
asked to do a practice task that involves this scary situation/object. 
 




Please circle ONE answer that matches your feeling. There are no right or wrong 
answers to these questions. We just want to know how sure you feel today.  
1. How sure are you that you can stay in a stressful/scary situation during the 
practice task? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                 
2. How sure are you that you can stay in a stressful/scary feeling (example: 
feeling scared, stressed, worried) during the practice task? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                
 
3. How sure are you that you can stay in a stressful/scary thought (example: 
thinking about something that is scary or stressful) during the practice task? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                
 
4. How sure are you that your fear will go down all by itself during the practice 
task? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                   
5. How sure are you that you will be able to lower your fear by yourself during 
the practice task? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                   
6. Over time, how sure are you that you will not be as scared of the 
situation/object during the practice task? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                   
7. How sure are you that practice tasks will help you be less afraid after you 
have been doing practice tasks for a while? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                  
8. How sure are you that practice tasks will help keep your fears from getting 
in the way of the things you want to do after you have been practicing for a 
while? 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure 
                                   
9. How sure are you that after you practice for a while with some help, practice 
tasks will help you stay less afraid 
Not sure at all      A tiny bit sure       Somewhat sure        Mostly Sure          Completely sure        
                                 
page 2 of 2
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Appendix D. Adapted and Created Study Measures 
Clinician Demographics Questionnaire 
 
Today’s Date ______________ 
 
1. Please indicate the number of years you have been working as a licensed psychologist 




2. Please indicate the number of years you have been working specifically in the field of 





3. Please indicate the number of years you have been utilizing cognitive behavioral 













Clinician Feedback Survey 
 
You have been invited to participate in this study because you have expertise in the field 
of anxiety disorders and obsessive-compulsive disorder (OCD). As a professional in the 
area, you have knowledge about the acute discomfort children and adolescents with 
anxiety disorders and OCD often experience during exposure practice in cognitive 
behavioral therapy with exposure or exposure with response prevention. Your expertise 
if valuable to us.  
 
Based on your opinion, please answer to the best of your ability the following questions 
about the Self-efficacy for Exposure – Child version (SEE-C). For each statement below, 
please indicate whether you strongly agree, agree, somewhat agree, are neutral, 
somewhat disagree, disagree, or strongly disagree.  
 
1. The items on this scale appear to represent self-efficacy. 
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 
1. Strongly Disagree 
 
2. The instructions on the Self-efficacy for Exposure – Child version are easy to follow. 
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 
1. Strongly Disagree 
 
3. The questions on the Self-efficacy for Exposure – Child version are clear and easy to 
follow. 
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 




4. Children and adolescents with anxiety disorders and/or obsessive-compulsive disorder 
will be able to understand and select an appropriate response (with minimal to moderate 
assistance) using the response scale on a cue card.  
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 
1. Strongly Disagree 
 
5. The layout of the questions on the Self-efficacy for Exposure – Child version are 
attractive.  
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 
1. Strongly Disagree 
 
6. The Self-efficacy for Exposure – Child version is at a reading level appropriate for an 
8-year old child. 
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 
1. Strongly Disagree 
 
7. A child with anxiety disorders and/or obsessive-compulsive disorder would not object 
to answering any items on the Self-efficacy for Exposure – Child version.  
 
7. Strongly Agree 
6. Agree 
5. Somewhat Agree 
4. Neutral 
3. Somewhat Disagree 
2. Disagree 











9. How long do you think it will take a child to complete the Self-efficacy for Exposure – 
Child version? 
 
1. < 5 minutes 
2. 5-10 minutes 
3. 11-15 minutes 
4. 16-20 minutes 
5. 21-25 minutes 
6. 26-30 minutes 
7. > 30 minutes 
 
10. During treatment, what is a reasonable length of time that you could spend 
completing this scale with a child? 
 
1. < 5 minutes 
2. 5-10 minutes 
3. 11-15 minutes 
4. 16-20 minutes 
5. 21-25 minutes 
6. 26-30 minutes 
7. > 30 minutes 
 
11. Based on your experience with children and adolescents with anxiety disorders and/or 
obsessive-compulsive disorder, what is a reasonable number of questions to include on 
the Self-efficacy for Exposure – Child version? 
 
1. < 5 questions 
2. 5-10 questions 
3. 11-15 questions 
4. 16-20 questions 
5. 21-25 questions 
6. 26-30 questions 
7. > 30 questions 
 



























17. Are there any other obstacles or challenges you see in patients reporting their self-























Semi-structured Administration Questionnaire 
1. Was the child able to understand the instructions of the Self-Efficacy During Exposure 
– Child version? 
 



























4. How much assistance did the child require? 
 














































Caregiver Demographics Sheet  
 
Today’s Date: _________________ 
 
Participant Name: ____________________________ 
 
Caregiver’s name: ______________________________ 
 
Address: _____________________________________________________________ 
                                                                                                                                  
Child’s Age:  __ __ (yrs) __ __ (mos)    
 
Child’s Sex:    Male (0)        Female (1) 
 
Child’s Ethnic Category:       Hispanic or Latino (1)        Not Hispanic or Latino (2)      
 
Child’s Racial Category:       Caucasian (1)        African-American (2)       
Asian/Pacific  Islander (3)     Native American (4)        Multi-racial (5)  
    Other (6), specify:_____________________________ 
 
 
Biological Parents:  
 
     Mother: Age: _____    
          Check highest level of education obtained: 
 __  did not graduate from high school (1) __  college graduate (4) 
 __  high school graduate (2)   __  advanced college degree (5) 
 __  some college (3) 
 
                     Occupation:_______________________ 
 
     Father: Age: _____    
          Check highest level of education obtained: 
 __  did not graduate from high school (1) __  college graduate (4) 
 __  high school graduate (2)   __  advanced college degree (5) 
 __  some college (3) 
                      
 Occupation:_______________________ 
 
Child’s biological parents are: 
 __  married and living together (1)                               __  mother deceased (6) 
 __  unmarried and living together (2)                           __  father deceased (7) 
 __  unmarried, not living together (3)                         __  both parents deceased (8) 
 __  divorced (4)                                                             __  unknown (9) 
 __  separated (5) 
 
The child lives with:    Biological mother and father  (1) 
    Single Parent:    Please note:    Mother  (2)      or       Father  (3) 
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    Mother and step-father  (4) 
    Father and step-mother  (5) 
    Equal time with separated/divorced parents  (6) 
    Adoptive parents  (6) 
    Other  
(0):_____________________________________________ 
 
Approximate Household Yearly Income:                  
   $20,000 or less (1)            $20,001 - $40,000 (2       $40,001 - $60,000 (3)      
   $60,001 - $80,000  (4)      $80,001 - $100,000 (5)     $100,000+ (6) 
       
Child’s siblings (list ages): 
 
 age age 
Full brothers:   
Full sisters:   
   
Half-brothers:   
Half sisters:   
   
Step brothers   
Step sisters   
 
Current School:      Public (1)     Private (2)     Home Studies (3)     Not in School 
(4)     Other (5) 
 
Grade:________________     
                                                              
Has child ever attended resource, remedial, or special classes in the past?      No (0)     
   Yes (1) 
 
 If yes, describe:_______________________________________________________ 
 
Has child ever repeated a grade?       No (0)    Yes (1)    If yes, describe: -
___________________ 
 
Current School Performance:      Failing (1)     Below Average (2)     Average (3)   
    Above Average (4) 
 
Psychiatric History: 
Has your child ever been hospitalized because of a behavioral, emotional, or psychiatric 
problem? 




Has your child suffered from any of the following medical problems? 
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 __  head injuries (concussions, loss of consciousness) __  allergic reactions to 
medications 
 __  seizures               __  other allergies 
 __  recurrent headaches              __  hospitalization for medical 
illness 
 __  bone fractures                          __  hearing impairment 
 __  asthma               __  surgery 
 __  other medical problems (describe) 




Please provide information about all medications that your child is currently taking: 
   




   
   
 
Please provide information about medications that your child has taken for psychiatric 
problems in the past: 
Past Medications Date started  
(mo/yr) 
Date stopped 
(mo/yr) Final Dose 
    
    
 
Have any other family members had psychiatric / emotional problems?            No      
  Yes 
If yes, please list relationship to child and problem experienced below:                                     
Relative 
 OCD Tics/ Anxiety Depression Drugs/ Schizophrenia
Other     Tourette’s   Alcohol  
Mother – 
biological 





            
  ___________ 
  
Sister:  Age 
____  
            
  ___________ 
  
Sister:  Age 
____   
            
  ___________ 
  
Brother:  Age 
____ 
            
  ___________ 
  
Brother:  Age 
____ 
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